ANDA 84326, held by Watson Labs. Nitrofurantoin.
As of Nov 14, 2026, ANDA 84326 (Nitrofurantoin), held by Watson Labs, was not approved, with 4 approved supplements and 0 published complete response letters.
| Nitrofurantoin50MG · capsule;oral | Nitrofurantoin | Discontinued |
| Nitrofurantoin100MG · capsule;oral | Nitrofurantoin | Discontinued |
| Feb 6, 1986 | Supplement 71Manufacturing | Approved | None posted |
| Feb 6, 1986 | Supplement 72Manufacturing | Approved | None posted |
| Feb 6, 1986 | Supplement 73Manufacturing | Approved | None posted |
| Jul 6, 1984 | Supplement 64Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
